Mondaq USA: Food, Drugs, Healthcare, Life Sciences > Food and Drugs Law
Thompson Coburn LLP
The concept of a "Right to Try" has been spreading through the U.S. over the last four years, beginning with the first passing of such laws in Colorado in 2014.
McDermott Will & Emery
In turn, the senator lifted holds on all Department of Justice nominees, ending an intra-GOP standoff over the Department's cannabis policy.
Morgan Lewis
In a much-anticipated decision in Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Ltd., the US Court of Appeals for the Federal Circuit on April 13 affirmed the district...
Frankfurt Kurnit Klein & Selz
Reuters reported yesterday that Google will start running ads again for drug treatment treaments, beginning the summer.
Day Pitney LLP
The President's decision ends a legislative blockade imposed by Gardner which has prevented the confirmation of 20 nominees to fill various positions within the Department of Justice.
BakerHostetler
President Trump earlier this year proposed boosting the FDA's budget by $473 million – to nearly $3.3 billion.
Sheppard Mullin Richter & Hampton
Historically, health plans and pharmacy benefit managers ("PBMs") have been uncomfortable neighbors. Plans provide drug coverage, but contract out the provision of such drugs to independent PBMs.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Last month, the Department of Health and Human Services' Office of Inspector General (OIG) released its latest report on compliance with the Drug Supply Chain Security Act (DSCSA).
Frankfurt Kurnit Klein & Selz
Worse, according to the complaint, the food made plaintiff's rescue dog, Bruce, sick, until plaintiff stopped buying Defendants' products.
Ropes & Gray LLP
The rules regarding truthful, non-misleading communications by medical product manufacturers have long been unclear.
Reed Smith
Breaking news. This just in. Prescriber's testimony linchpin in manufacturer's victory over failure to warn claims.
Sheppard Mullin Richter & Hampton
Medicare Part C and Part D Star Ratings are used by CMS to measure the quality of and reflect the experiences of beneficiaries in Medicare Advantage ("MA") and Prescription Drug Plans ("PDPs").
Troutman Sanders LLP
Should vapor products be regulated the same, regardless of whether they contain nicotine? A bill before the Louisiana State Legislature would accomplish just that ...
Reed Smith
Today's guest post by Reed Smith associate Jennifer Eppensteiner concerns an interesting First Amendment development.
Seyfarth Shaw LLP
As previously reported here, on November 8, 2016, Maine voters approved "Question 1 – An Act to Legalize Marijuana" (the Act), which allows for, among other things, the recreational use of marijuana.
Foley Hoag LLP
Foley Hoag's Product Liability Update is a quarterly update concerning developments in product liability and related law of interest to product manufacturers and sellers.
BakerHostetler
In early March 2018, the Food and Drug Administration (FDA) released a few more details to the food and beverage industry about how to adapt to the first major revamp of nutrition labels in years.
Troutman Sanders LLP
In connection with FDA Commissioner Scott Gottleib's July 2017 announcement regarding a new comprehensive nicotine strategy, the FDA ...
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
This week, Congress returns from recess with its eyes set on addressing the opioid crisis.
Holland & Knight
In 2016, through the Comprehensive Addiction and Recovery Act (CARA) and the 21st Century Cures Act, Congress authorized roughly $1.4 billion in spending to combat the opioid crisis.
Latest Video
Most Popular Recent Articles
Reed Smith
With plaintiffs desperate to find some way to continue pursuing aggravated, aggregated product liability litigation in their favorite venues after Daimler AG v. Bauman ...
Wilson Elser Moskowitz Edelman & Dicker LLP
On March 16, 2018, Massachusetts's highest court , the Supreme Judicial Court, issued a ruling that we believe will increase the product liability risk exposure for pharmaceutical manufacturers in the state.
Akin Gump Strauss Hauer & Feld LLP
Despite the headlines coming out of Washington, Congress continues to move forward in regular fashion, discussing and acting upon key issues, such as funding the government, addressing the need...
Reed Smith
This morning, our commuter train was packed with overjoyed Villanova students headed for the NCAA Championship Victory Parade.
Seyfarth Shaw LLP
On March 9, 2018, the Massachusetts Cannabis Control Commission ("CCC") filed its much anticipated recreational marijuana Regulations with the Massachusetts Secretary of State. According to the CCC, the Regulations ...
BakerHostetler
President Trump earlier this year proposed boosting the FDA's budget by $473 million – to nearly $3.3 billion.
Holland & Knight
On March 23, 2018, the U.S. Food and Drug Administration (FDA) released draft guidance regarding the process through which it proposes to evaluate bulk drug ...
Akin Gump Strauss Hauer & Feld LLP
In a Report and Recommendation issued December 7, 2017, Magistrate Judge Burke in the District of Delaware recommended that Amgen's BPCIA ...
Thompson Coburn LLP
Facing a consumer fraud lawsuit based on your product's "non-GMO" or "GMO-free" labeling?
Marshall, Gerstein & Borun LLP
A patent relating to a method of treating rheumatoid arthritis using rituximab recently survived its fourth IPR challenge. Celltrion, Inc. v. Biogen, Inc., IPR2016-01614 (PTAB Feb. 21, 2018).
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with